Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients

被引：0
|
作者：
Pinelli, Valentina
Fini, Donatella
Battolla, Enrico
Ferro, Paola
Franceschini, Maria Cristiana
Fontana, Vincenzo
Pistillo, Maria Pia
Roncella, Silvio
Canessa, Pier Aldo
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Mesothelioma; Pleura; Biomarkers;
D O I：
10.1183/13993003.congress-2016.PA5075
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA5075
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma
    Creaney, Jenette
    Dick, Ian M.
    Robinson, Bruce W.
    CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (04) : 352 - 356
  • [2] Fibulin-3: A Potential Prognostic Biomarker in Malignant Pleural Mesothelioma?
    Kirschner, Michaela B.
    Pulford, Emily
    Hoda, Mir A.
    Rozsas, Anita
    Griggs, Kim
    Edelman, J. James B.
    Kao, Steven
    Hyland, Rebecca
    Dong, Yawen
    Laszlo, Viktoria
    Klikovits, Thomas
    Jakopovic, Marko
    Vallely, Michael
    Grusch, Michael
    Hegedus, Balazs
    Dome, Balazs
    Klepetko, Walter
    Van Zandwijk, Nico
    Klebe, Sonja
    Reid, Glen
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S747 - S747
  • [3] Role of fibulin-3 in the diagnosis of malignant mesothelioma
    Agha, Mohammed
    El-habashy, Mahmoud
    El-Shazly, Rania
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [4] Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial
    Katz, Sharyn, I
    Roshkovan, Leonid
    Berger, Ian
    Friedberg, Joseph S.
    Alley, Evan W.
    Simone, Charles B., II
    Haas, Andrew R.
    Cengel, Keith A.
    Sterman, Daniel H.
    Albelda, Steven M.
    LUNG CANCER, 2021, 154 : 5 - 12
  • [5] Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis
    Ren, Ran
    Yin, Pengpeng
    Zhang, Yan
    Zhou, Jianyun
    Zhou, Yixing
    Xu, Rufu
    Lin, Hai
    Huang, Chunji
    ONCOTARGET, 2016, 7 (51) : 84851 - 84859
  • [6] Dysphagia in Patients with Malignant Pleural Mesothelioma (MPM)
    Malec, M.
    Desai, A.
    Waxman, I.
    Karrison, T.
    Rose, B.
    Mendoza, A.
    Gadiraju, M.
    Straus, C.
    Churpek, J.
    Kindler, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S759 - S760
  • [7] Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis
    Pei, Dongxu
    Li, Yongwei
    Liu, Xinwei
    Yan, Sha
    Guo, Xiaolan
    Xu, Xiaona
    Guo, Xiaoxia
    ONCOTARGET, 2017, 8 (08) : 13030 - 13038
  • [8] Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma
    Yamada, Shusai
    Tabata, Chiharu
    Tabata, Rie
    Fukuoka, Kazuya
    Nakano, Takashi
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (10) : 1721 - 1726
  • [9] Fibulin-3 immunoexpression in malignant mesothelioma due to fluoro-edenite: a preliminary report
    Caltabiano, Rosario
    Loreto, Carla
    Vitale, Ermanno
    Matera, Serena
    Miozzi, Edoardo
    Migliore, Marcello
    Angelico, Giuseppe
    Tumino, Rosario
    Ledda, Caterina
    Rapisarda, Venerando
    FUTURE ONCOLOGY, 2018, 14 (06) : 53 - 57
  • [10] Kinetics of Soluble Mesothelin in Patients with Malignant Pleural Mesothelioma during Treatment
    Grigoriu, Bogdan D.
    Chahine, Bachar
    Vachani, Anil
    Gey, Thomas
    Conti, Massimo
    Sterman, Daniel H.
    Marchandise, Genevieve
    Porte, Henri
    Albelda, Steven M.
    Scherpereel, Arnaud
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (10) : 950 - 954
12345